Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	143	58	276	380	92	42
Market Cap Growth	-61.32%	-79.15%	-27.49%	315.51%	117.68%	-40.54%
Enterprise Value	144	59	260	372	73	48
Last Close Price	6.06	4.42	24.40	43.40	14.40	29.80
PE Ratio	-	-0.94	-3.92	-6.23	-1.07	-0.75
PS Ratio	-	-	-	-	-	5.16
PB Ratio	-2.06	-3.98	31.58	82.58	32.40	-3.91
P/FCF Ratio	-2.68	-1.34	-4.87	-7.01	-2.88	-1.29
P/OCF Ratio	-2.68	-1.34	-4.87	-7.01	-2.88	-1.30
EV/Sales Ratio	-	-	-	-	-	5.92
EV/EBITDA Ratio	-2.78	-1.10	-4.14	-7.24	-2.03	-2.23
EV/EBIT Ratio	-2.78	-1.10	-4.13	-7.20	-2.00	-1.93
EV/FCF Ratio	-2.64	-1.36	-4.59	-6.87	-2.28	-1.47
Debt / Equity Ratio	-0.39	-2.46	1.25	2.58	1.71	-1.39
Debt / FCF Ratio	-0.51	-0.83	-0.19	-0.22	-0.15	-0.46
Asset Turnover	-	-	-	-	-	0.41
Quick Ratio	0.75	0.50	0.88	2.14	0.84	0.45
Current Ratio	1.07	0.66	1.39	3.19	1.13	0.67
Return on Equity (ROE)	-	-	-989.99%	-1430.33%	-	-
Return on Assets (ROA)	-83.69%	-109.17%	-153.56%	-151.98%	-123.12%	-79.37%
Return on Capital (ROIC)	-	-162.72%	-217.76%	-267.59%	-383.73%	-590.69%
Earnings Yield	-65.61%	-102.55%	-23.94%	-13.97%	-38.48%	-82.07%
FCF Yield	-45.03%	-74.72%	-20.54%	-14.26%	-34.72%	-77.80%
Buyback Yield / Dilution	-32.01%	-17.96%	-38.91%	-110.43%	-298.84%	-268.84%
Total Shareholder Return	-32.01%	-17.96%	-38.91%	-110.43%	-298.84%	-268.84%

Source: S&P Capital IQ. Standard template. Financial Sources.